The role of AngII in the alterations of glomerular hemodynamics in hypertension has been described in detail and has fostered the development of numerous anti-hypertensive therapies targeting AngII formation and receptor interactions that reduce glomerular injury in hypertension. This evidence concerns the gene AGT and Hypertension.